Novartis AG (NVS)
NYSE: NVS · IEX Real-Time Price · USD
+1.04 (1.00%)
At close: Jun 12, 2024, 4:00 PM
+0.09 (0.09%)
Pre-market: Jun 13, 2024, 5:53 AM EDT

Novartis AG Revenue

Novartis AG had revenue of $49.92B in the twelve months ending March 31, 2024, with 8.81% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $12.12B with 9.71% year-over-year growth. In the year 2023, Novartis AG had annual revenue of $46.66B with 7.36% growth.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
206.51B USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 202346.66B3.20B7.36%
Dec 31, 202243.46B-513.00M-1.17%
Dec 31, 202143.97B-5.92B-11.87%
Dec 31, 202049.90B1.22B2.51%
Dec 31, 201948.68B2.58B5.59%
Dec 31, 201846.10B2.70B6.21%
Dec 31, 201743.40B-6.03B-12.20%
Dec 31, 201649.44B-951.00M-1.89%
Dec 31, 201550.39B-3.25B-6.05%
Dec 31, 201453.63B918.00M1.74%
Dec 31, 201352.72B745.00M1.43%
Dec 31, 201251.97B-7.40B-12.47%
Dec 31, 201159.38B7.81B15.15%
Dec 31, 201051.56B6.46B14.32%
Dec 31, 200945.10B2.52B5.92%
Dec 31, 200842.58B3.64B9.34%
Dec 31, 200738.95B3.84B10.94%
Dec 31, 200635.11B5.35B17.99%
Dec 31, 200529.75B2.48B9.08%
Dec 31, 200427.28B2.35B9.41%
Dec 31, 200324.93B4.05B19.41%
Dec 31, 200220.88B2.12B11.27%
Dec 31, 200118.76B-3.07B-14.06%
Dec 31, 200021.83B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Johnson & Johnson 81.80B
Merck & Co. 61.40B
Pfizer 55.09B
AbbVie 54.40B
AstraZeneca 47.61B
Thermo Fisher 42.49B
Abbott Laboratories 40.33B
Amgen 29.53B
Revenue Rankings